Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Study of IV Ketamine for Emergency Department Treatment of Adolescent Suicidal Ideation
Children's Hospital of Eastern Ontario
Fentanyl or Esketamine for Traumatic PAIN (FORE-PAIN) Trial
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL)
Ottawa Hospital Research Institute
i-CBT and IV Ketamine for Suicidality in Treatment-Resistant Depression: A Randomized, Midazolam-Controlled Clinical Trial
University Health Network, Toronto
Etomidate Versus Propofol in CABG Surgery
Hartford Hospital
Effect of Ketamine on Intraoperative Motor Evoked Potentials
University of California, San Francisco
Psilocybin Therapy for Chronic Low Back Pain
Joshua Woolley, MD, PhD
Prehospital Analgesia INtervention Trial (PAIN)
Jason Sperry
IN Midazolam vs IN Dexmedetomidine vs IN Ketamine During Minimal Procedures in Pediatric ED
University of Oklahoma
Reducing Postoperative Opioids in Patients Undergoing Laparoscopic Hiatal Hernia
Endeavor Health
5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder
Johns Hopkins University
Psilocybin-facilitated Treatment for Chronic Pain
University of Alabama at Birmingham
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
Biogen
Two Doses of Psilocybin for the Treatment of MDD in Adults With Cancer
Sunstone Medical
HNC: Human Neural Circuits Electrophysiology During Cognition
Stanford University
RIVER At Home Ketamine Protocols
RIVER Foundation
The Anaesthetic Ketamine as Treatment for Patients With Severe Acute Brain Injury
Rigshospitalet, Denmark
Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
Yale University
Enhancing Week-long Psychological Treatment for PTSD With Ketamine
Yale University
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
Oregon Health and Science University
Does Psilocybin Require Psychedelic Effects to Treat Depression?
Centre for Addiction and Mental Health
Psilocybin Therapy in Advanced Cancer
NYU Langone Health
Opioid-free Analgesia in Intensive Care Unit
Centre Hospitalier Universitaire de Nīmes
Oral Ketamine for Treatment of Vaso-Occlusive Pain
Boston Children's Hospital
Different Treatments in Chronic Pain Patients.
University Ghent
The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects
Yale University
Metabolic Profiling of Esketamine Treatment in Depressive Disorder
University of Zagreb
IV Ketamine Vs. in Esketamine for MDD TRD
Gustavo Vazquez
Study of the Neural Circuits Underlying the Negative Emotional Bias of Depressive Disorders and Their Response to Ketamine
Centre Hospitalier St Anne
Evaluation of the Effectiveness of the Administration of Local Anesthetics Via Two Catheters Placed During Surgery, and Study of the Benefits on Respiratory Function and Therefore on Recovery Time
CHU de Reims
Ketamine & Crisis Response Plan for Suicidal Ideation in the ED
The University of Texas Health Science Center at San Antonio
Ketamine Treatment Plans for Chronic Conditions
RIVER Foundation
Opioid-free Anaesthesia in Breast Cancer Surgery
University of Ioannina
Improving Neurotrauma by Depolarization Inhibition With Combination Therapy (INDICT)
University of Cincinnati
Glutamatergic Adaptation to Stress as a Mechanism for Anhedonia and Treatment Response With Ketamine
Emory University
Esketamine Nasal Spray in Real-World Settings in Treatment-Resistant Depression
Riccardo Guglielmo
Comparison of Esketamine/Propofol and Methohexital Anesthesia for ECT
Medical University of Vienna
Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer
Cedars-Sinai Medical Center
Long-Term Maintenance With Ketamine and Esketamine for Reduction of Suicide in High-Risk Patients With Depression
Massachusetts General Hospital
MDMA-assisted Therapy for Adjustment Disorder (AD) in Dyads of Patients With Cancer and a Concerned Significant Other
Sunstone Medical
Dexmedetomidine Versus Propofol Sedation for Drug-Induced Sleep Endoscopy in Pediatric Obstructive Sleep Apnea
Erin Kirkham
Ketamine in OCD: Efficacy and Effects on Stress and Cognition
Medical University of Vienna
The Efficacy of a Subanesthetic Doses of IV Ketamine in the Treatment Drug Resistant Epilepsy
Madeline Fields
Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder
Portland VA Research Foundation, Inc
Glutamate Emotion Memory Study
University of Oxford
Ketamine Treatment of Youth Suicide Attempters
Tatiana Falcone, MD
Multiparametric Assessment to Investigate Prognostic Factors for Disease Evolution a nd Evolutionary Patterns of Cognitive Status in RRMS
University Hospital of Mont-Godinne
The Effect of Ketamine on Aesthetics and Role for Antidepressant Effects
Medical University of Vienna
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.